Literature DB >> 18484101

Age and region-specific responses of microglia, but not astrocytes, suggest a role in selective vulnerability of dopamine neurons after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure in monkeys.

Nicholas M Kanaan1, Jeffrey H Kordower, Timothy J Collier.   

Abstract

Little is known about the effects of aging, the strongest risk factor for Parkinson's disease (PD), on glial responses to dopamine (DA) neuron degeneration in midbrain subregions that display selective vulnerability to degeneration. We evaluated the impact of aging on astrocytes and microglia in a regionally specific manner in a monkey model of PD. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was delivered unilaterally via the internal carotid artery of young, middle-aged, and old-aged rhesus monkeys. Astrocytes and microglia were identified using glial fibrillary acidic protein and human leukocyte antigen-DR (HLA-DR) immunolabeling, respectively. Glial reactivity was assessed using (1) stereological cell counting, (2) fluorescence intensity, and (3) a morphology rating scale. In the midbrain contralateral and ipsilateral to the MPTP injection, astrocyte number and intensity did not change with age. In both sides of the midbrain, cellular morphology suggested astrocyte hypertrophy in middle-age dissipated in old-age, irrespective of DA subregion and regional differences in vulnerability to degeneration. In the contralateral midbrain, microglia became mildly activated (increased cell number and intensity, and morphological changes) with advancing age. Inflammation was evident at 3 months postlesion by severe microglial activation in the ipsilateral midbrain. HLA-DR fluorescence intensity and an abundance of activated microglia (based on morphological criteria) were consistently exacerbated in the vtSN of both sides of the midbrain. These results suggest the glial responses accompanying aging and DA neuron degeneration following a toxic insult represent persistent alterations in the microenvironment of surviving DA neurons that are important factors in understanding regional differences in susceptibility to degeneration. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18484101      PMCID: PMC3388430          DOI: 10.1002/glia.20690

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  60 in total

1.  The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease.

Authors:  B Mirza; H Hadberg; P Thomsen; T Moos
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

Review 2.  Astrocytes and Parkinson's disease.

Authors:  L S Forno; L E DeLanney; I Irwin; D Di Monte; J W Langston
Journal:  Prog Brain Res       Date:  1992       Impact factor: 2.453

3.  Differential regulation of astrocytic mRNAs in the rat striatum after lesions of the cortex or substantia nigra.

Authors:  P E Schauwecker; J P Cogen; T Jiang; H W Cheng; T J Collier; T H McNeill
Journal:  Exp Neurol       Date:  1998-01       Impact factor: 5.330

4.  Systemic administration of the immunophilin ligand GPI 1046 in MPTP-treated monkeys.

Authors:  M E Emborg; P Shin; B Roitberg; J G Sramek; Y Chu; G T Stebbins; J S Hamilton; P D Suzdak; J P Steiner; J H Kordower
Journal:  Exp Neurol       Date:  2001-03       Impact factor: 5.330

5.  Unbiased stereological estimation of the number of neurons in the human hippocampus.

Authors:  M J West; H J Gundersen
Journal:  J Comp Neurol       Date:  1990-06-01       Impact factor: 3.215

6.  Ageing and Parkinson's disease: substantia nigra regional selectivity.

Authors:  J M Fearnley; A J Lees
Journal:  Brain       Date:  1991-10       Impact factor: 13.501

7.  Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism.

Authors:  C C Chao; S Hu; W S Sheng; D Bu; M I Bukrinsky; P K Peterson
Journal:  Glia       Date:  1996-03       Impact factor: 7.452

8.  Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat.

Authors:  M N Gordon; W A Schreier; X Ou; L A Holcomb; D G Morgan
Journal:  J Comp Neurol       Date:  1997-11-10       Impact factor: 3.215

9.  Glutathione peroxidase, glial cells and Parkinson's disease.

Authors:  P Damier; E C Hirsch; P Zhang; Y Agid; F Javoy-Agid
Journal:  Neuroscience       Date:  1993-01       Impact factor: 3.590

10.  Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-05       Impact factor: 10.154

View more
  33 in total

1.  Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.

Authors:  Jessica M Crain; Jyoti J Watters
Journal:  Open Drug Discov J       Date:  2010-01-01

2.  Evidence of angiogenic vessels in Alzheimer's disease.

Authors:  Brinda S Desai; Julie A Schneider; Jia-Liang Li; Paul M Carvey; Bill Hendey
Journal:  J Neural Transm (Vienna)       Date:  2009-04-16       Impact factor: 3.575

3.  Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF.

Authors:  M E Emborg; J Moirano; J Raschke; V Bondarenko; R Zufferey; S Peng; A D Ebert; V Joers; B Roitberg; J E Holden; J Koprich; J Lipton; J H Kordower; P Aebischer
Journal:  Neurobiol Dis       Date:  2009-08-04       Impact factor: 5.996

4.  Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease.

Authors:  Stefka Gyoneva; Lauren Shapiro; Carlos Lazo; Ethel Garnier-Amblard; Yoland Smith; Gary W Miller; Stephen F Traynelis
Journal:  Neurobiol Dis       Date:  2014-03-13       Impact factor: 5.996

5.  Age-Related Decrease in Tyrosine Hydroxylase Immunoreactivity in the Substantia Nigra and Region-Specific Changes in Microglia Morphology in HIV-1 Tg Rats.

Authors:  David R Goulding; Andrew Kraft; Peter R Mouton; Christopher A McPherson; Valeria Avdoshina; Italo Mocchetti; G Jean Harry
Journal:  Neurotox Res       Date:  2019-07-08       Impact factor: 3.911

6.  Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy.

Authors:  Brinda Desai Bradaric; Aditiben Patel; Julie A Schneider; Paul M Carvey; Bill Hendey
Journal:  J Neural Transm (Vienna)       Date:  2011-07-12       Impact factor: 3.575

7.  Association Between Microglia, Inflammatory Factors, and Complement with Loss of Hippocampal Mossy Fiber Synapses Induced by Trimethyltin.

Authors:  Andrew D Kraft; Christopher A McPherson; G Jean Harry
Journal:  Neurotox Res       Date:  2016-02-18       Impact factor: 3.911

Review 8.  Contributions of Nonhuman Primates to Research on Aging.

Authors:  E S Didier; A G MacLean; M Mohan; P J Didier; A A Lackner; M J Kuroda
Journal:  Vet Pathol       Date:  2016-02-11       Impact factor: 2.221

Review 9.  α-Synuclein nonhuman primate models of Parkinson's disease.

Authors:  David J Marmion; Jeffrey H Kordower
Journal:  J Neural Transm (Vienna)       Date:  2017-04-22       Impact factor: 3.575

Review 10.  A dual-hit animal model for age-related parkinsonism.

Authors:  Heather A Boger; Ann-Charlotte Granholm; Jacqueline F McGinty; Lawrence D Middaugh
Journal:  Prog Neurobiol       Date:  2009-10-21       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.